Global Remdesivir (COVID-19) Market 2020 by Manufacturers, Type and Application, Forecast to 2025

  • receipt Report ID : 82390
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Remdesivir (COVID-19) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Remdesivir (COVID-19) sales will be xx in 2020 from Remdesivir (COVID-19) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Remdesivir (COVID-19) market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Remdesivir (COVID-19) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Remdesivir (COVID-19) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation

Remdesivir (COVID-19) market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Remdesivir (COVID-19) market has been segmented into 5mg, 10mg, 50mg, 100mg, etc.

Breakdown by Application, Remdesivir (COVID-19) has been segmented into Hospital, Clinics, Drug Store, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Remdesivir (COVID-19) market presented in the report. This section sheds light on the sales growth of different regional and country-level Remdesivir (COVID-19) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Remdesivir (COVID-19) market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Remdesivir (COVID-19) Market Share Analysis

Remdesivir (COVID-19) competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Remdesivir (COVID-19) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Remdesivir (COVID-19) sales, revenue and market share for each player covered in this report.

The major players covered in Remdesivir (COVID-19) are: Gilead Sciences, Inovio Pharmaceuticals, Kelun Pharma, Bright Gene, Berry Global Group, Hainan Haiyao, Borui Bio-Pharmaceutical, Hunan Warrant Pharmaceutical, etc. Among other players domestic and global, Remdesivir (COVID-19) market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global Remdesivir (COVID-19) market are listed below:

Gilead Sciences

Inovio Pharmaceuticals

Kelun Pharma

Bright Gene

Berry Global Group

Hainan Haiyao

Borui Bio-Pharmaceutical

Hunan Warrant Pharmaceutical

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:

5mg

10mg

50mg

100mg

Market segment by Application, can be divided into

Hospital

Clinics

Drug Store

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Remdesivir (COVID-19) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Remdesivir (COVID-19) Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 5mg

1.2.3 10mg

1.2.4 50mg

1.2.5 100mg

1.3 Market Analysis by Application

1.3.1 Overview: Global Remdesivir (COVID-19) Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Drug Store

1.3.5 Others

1.4 Global Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

1.4.1 Global Remdesivir (COVID-19) Revenue and Forecast (2015-2025)

1.4.2 Global Remdesivir (COVID-19) Sales and Forecast (2015-2025)

1.5 Global Remdesivir (COVID-19) Market Size Overview by Geography (2015-2020)

1.6 COVID-19 Outbreak: Remdesivir (COVID-19) Industry Impact

1.6.1 COVID-19 Potential Implications for the Remdesivir (COVID-19)

1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Remdesivir (COVID-19)

1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April

1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4

1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2

1.6.2 Opportunity Analysis in Covid-19 Crisis

1.6.3 Market Risk and Restraints

1.6.4 Market Driving Force

2 Manufacturers Profiles

2.1 Gilead Sciences

2.1.1 Gilead Sciences Details

2.1.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Gilead Sciences SWOT Analysis

2.1.4 Gilead Sciences Product and Services

2.1.5 Gilead Sciences Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Inovio Pharmaceuticals

2.2.1 Inovio Pharmaceuticals Details

2.2.2 Inovio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Inovio Pharmaceuticals SWOT Analysis

2.2.4 Inovio Pharmaceuticals Product and Services

2.2.5 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Kelun Pharma

2.3.1 Kelun Pharma Details

2.3.2 Kelun Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Kelun Pharma SWOT Analysis

2.3.4 Kelun Pharma Product and Services

2.3.5 Kelun Pharma Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Bright Gene

2.4.1 Bright Gene Details

2.4.2 Bright Gene Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Bright Gene SWOT Analysis

2.4.4 Bright Gene Product and Services

2.4.5 Bright Gene Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Berry Global Group

2.5.1 Berry Global Group Details

2.5.2 Berry Global Group Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Berry Global Group SWOT Analysis

2.5.4 Berry Global Group Product and Services

2.5.5 Berry Global Group Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Hainan Haiyao

2.6.1 Hainan Haiyao Details

2.6.2 Hainan Haiyao Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Hainan Haiyao SWOT Analysis

2.6.4 Hainan Haiyao Product and Services

2.6.5 Hainan Haiyao Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Borui Bio-Pharmaceutical

2.7.1 Borui Bio-Pharmaceutical Details

2.7.2 Borui Bio-Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Borui Bio-Pharmaceutical SWOT Analysis

2.7.4 Borui Bio-Pharmaceutical Product and Services

2.7.5 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Hunan Warrant Pharmaceutical

2.8.1 Hunan Warrant Pharmaceutical Details

2.8.2 Hunan Warrant Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Hunan Warrant Pharmaceutical SWOT Analysis

2.8.4 Hunan Warrant Pharmaceutical Product and Services

2.8.5 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Global Remdesivir (COVID-19) Market, Company Landscape

3.1 Company Market Share Analysis: Global

3.1.1 Global Remdesivir (COVID-19) Sales and Market Share by Manufacturer (2018-2019)

3.1.2 Global Remdesivir (COVID-19) Revenue and Market Share by Manufacturer (2018-2019)

3.2 Company Market Share Analysis: China

3.2.1 Key Players Remdesivir (COVID-19) Sales in China (2018-2019)

3.2.2 China Remdesivir (COVID-19) Revenue Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Remdesivir (COVID-19) Manufacturer Market Share in 2019

3.3.2 Top 6 Remdesivir (COVID-19) Manufacturer Market Share in 2019

4 Market Size by Geography

4.1 Global Remdesivir (COVID-19) Market Size by Geography (2015-2020)

4.1.1 Global Remdesivir (COVID-19) Sales by Geography (2015-2020)

4.1.2 Global Remdesivir (COVID-19) Revenue by Regions (2015-2020)

4.2 Global Remdesivir (COVID-19) Market Size and Forecast by Regions (2020-2025)

4.2.1 Global Remdesivir (COVID-19) Sales and Forecast by Regions (2020-2025)

4.2.2 Global Remdesivir (COVID-19) Revenue and Forecast by Regions (2020-2025)

4.3 North America Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

4.4 Europe Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

4.5 Asia-Pacific Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

4.6 South America Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

4.7 Middle East and Africa Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

5 North America by Country

5.1 North America Remdesivir (COVID-19) Market Size by Country (2015-2020)

5.1.1 North America Remdesivir (COVID-19) Sales and Market Share by Country (2015-2020)

5.1.2 North America Remdesivir (COVID-19) Revenue and Market Share by Country (2015-2020)

5.2 North America Remdesivir (COVID-19) Market Size and Forecast by Country (2020-2025)

5.2.1 North America Remdesivir (COVID-19) Sales and Forecast by Country (2020-2025)

5.2.2 North America Remdesivir (COVID-19) Revenue and Forecast by Country (2020-2025)

5.3 United States Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

5.4 Canada Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

5.5 Mexico Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

6 Europe by Country

6.1 Europe Remdesivir (COVID-19) Market Size by Country (2015-2020)

6.1.1 Europe Remdesivir (COVID-19) Sales by Country (2015-2020)

6.1.2 Europe Remdesivir (COVID-19) Revenue by Country (2015-2020)

6.2 Europe Remdesivir (COVID-19) Market Size and Forecast by Country (2020-2025)

6.2.1 Europe Remdesivir (COVID-19) Sales and Forecast by Country (2020-2025)

6.2.2 Europe Remdesivir (COVID-19) Revenue and Forecast by Country (2020-2025)

6.3 Germany Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

6.4 United Kingdom Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

6.5 France Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

6.6 Russia Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

6.7 Italy Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Remdesivir (COVID-19) Market Size by Region (2015-2020)

7.1.1 Asia-Pacific Remdesivir (COVID-19) Sales by Region (2015-2020)

7.1.2 Asia-Pacific Remdesivir (COVID-19) Revenue by Region (2015-2020)

7.2 Asia-Pacific Remdesivir (COVID-19) Market Size and Forecast by Region (2020-2025)

7.2.1 Asia-Pacific Remdesivir (COVID-19) Sales and Forecast by Region (2020-2025)

7.2.2 Asia-Pacific Remdesivir (COVID-19) Revenue and Forecast by Region (2020-2025)

7.3 China Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

7.4 Japan Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

7.5 Korea Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

7.6 India Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

7.7 Southeast Asia Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

7.8 Australia Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

8 South America by Country

8.1 South America Remdesivir (COVID-19) Market Size by Country (2015-2020)

8.1.1 South America Remdesivir (COVID-19) Sales by Country (2015-2020)

8.1.2 South America Remdesivir (COVID-19) Revenue by Country (2015-2020)

8.2 South America Remdesivir (COVID-19) Market Size and Forecast by Country (2020-2025)

8.2.1 South America Remdesivir (COVID-19) Sales and Forecast by Country (2020-2025)

8.2.2 South America Remdesivir (COVID-19) Revenue and Forecast by Country (2020-2025)

8.3 Brazil Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

8.4 Argentina Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Remdesivir (COVID-19) Market Size by Country (2015-2020)

9.1.1 Middle East & Africa Remdesivir (COVID-19) Sales by Country (2015-2020)

9.1.2 Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2015-2020)

9.2 Middle East & Africa Remdesivir (COVID-19) Market Size and Forecast by Country (2020-2025)

9.2.1 Middle East & Africa Remdesivir (COVID-19) Sales and Forecast by Country (2020-2025)

9.2.2 Middle East & Africa Remdesivir (COVID-19) Revenue and Forecast by Country (2020-2025)

9.3 Saudi Arabia Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

9.4 Turkey Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

9.5 Egypt Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

9.6 South Africa Remdesivir (COVID-19) Market Size and Forecast (2015-2025)

10 Market Segment by Type

10.1 Global Remdesivir (COVID-19) Market Size by Type (2015-2020)

10.1.1 Global Remdesivir (COVID-19) Sales by Type (2015-2020)

10.1.2 Global Remdesivir (COVID-19) Revenue by Type (2015-2020)

10.1.3 Global Remdesivir (COVID-19) Price by Type (2015-2020)

10.2 Global Remdesivir (COVID-19) Market Size and Forecast by Type (2020-2025)

10.2.1 Global Remdesivir (COVID-19) Sales and Forecast by Type (2020-2025)

10.2.2 Global Remdesivir (COVID-19) Revenue and Forecast by Type (2020-2025)

10.2.3 Global Remdesivir (COVID-19) Price and Forecast by Type (2020-2025)

10.3 China Remdesivir (COVID-19) Market Size and Forecast by Type (2015-2025)

10.3.1 China Remdesivir (COVID-19) Market Size by Type (2015-2020)

10.3.2 China Remdesivir (COVID-19) Market Size and Forecast by Type (2020-2025)

11 Market Segment by Application

11.1 Global Remdesivir (COVID-19) Market Size by Application (2015-2020)

11.1.1 Global Remdesivir (COVID-19) Sales by Application (2015-2020)

11.1.2 Global Remdesivir (COVID-19) Revenue by Application (2015-2020)

11.1.3 Global Remdesivir (COVID-19) Price by Application (2015-2020)

11.2 Global Remdesivir (COVID-19) Market Size and Forecast by Application (2020-2025)

11.2.1 Global Remdesivir (COVID-19) Sales and Forecast by Application (2020-2025)

11.2.2 Global Remdesivir (COVID-19) Revenue and Forecast by Application (2020-2025)

11.2.3 Global Remdesivir (COVID-19) Price and Forecast by Application (2020-2025)

11.3 China Remdesivir (COVID-19) Market Size and Forecast by Application (2015-2025)

11.3.1 China Remdesivir (COVID-19) Market Size by Application (2015-2020)

11.3.2 China Remdesivir (COVID-19) Market Size and Forecast by Application (2020-2025)

12 Sales Channel, Distributors, Costumers, and Market Dynamics

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

12.4.1 Market Opportunities

12.4.2 Market Risk

12.4.3 Market Driving Force

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Remdesivir (COVID-19) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Remdesivir (COVID-19) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Remdesivir (COVID-19) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Remdesivir (COVID-19) Market Size Overview by Geography (2015-2020) (USD Million)

Table 5. Global Remdesivir (COVID-19) Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Gilead Sciences Basic Information, Manufacturing Base and Competitors

Table 7. Gilead Sciences Remdesivir (COVID-19) Major Business

Table 8. Gilead Sciences Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 9. Gilead Sciences SWOT Analysis

Table 10. Gilead Sciences Remdesivir (COVID-19) Product and Services

Table 11. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 12. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 13. Inovio Pharmaceuticals Remdesivir (COVID-19) Major Business

Table 14. Inovio Pharmaceuticals Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 15. Inovio Pharmaceuticals SWOT Analysis

Table 16. Inovio Pharmaceuticals Remdesivir (COVID-19) Product and Services

Table 17. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 18. Kelun Pharma Basic Information, Manufacturing Base and Competitors

Table 19. Kelun Pharma Remdesivir (COVID-19) Major Business

Table 20. Kelun Pharma Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 21. Kelun Pharma SWOT Analysis

Table 22. Kelun Pharma Remdesivir (COVID-19) Product and Services

Table 23. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 24. Bright Gene Basic Information, Manufacturing Base and Competitors

Table 25. Bright Gene Remdesivir (COVID-19) Major Business

Table 26. Bright Gene Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 27. Bright Gene SWOT Analysis

Table 28. Bright Gene Remdesivir (COVID-19) Product and Services

Table 29. Bright Gene Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 30. Berry Global Group Basic Information, Manufacturing Base and Competitors

Table 31. Berry Global Group Remdesivir (COVID-19) Major Business

Table 32. Berry Global Group Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 33. Berry Global Group SWOT Analysis

Table 34. Berry Global Group Remdesivir (COVID-19) Product and Services

Table 35. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 36. Hainan Haiyao Basic Information, Manufacturing Base and Competitors

Table 37. Hainan Haiyao Remdesivir (COVID-19) Major Business

Table 38. Hainan Haiyao Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 39. Hainan Haiyao SWOT Analysis

Table 40. Hainan Haiyao Remdesivir (COVID-19) Product and Services

Table 41. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 42. Borui Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 43. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Major Business

Table 44. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 45. Borui Bio-Pharmaceutical SWOT Analysis

Table 46. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product and Services

Table 47. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 48. Hunan Warrant Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 49. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Major Business

Table 50. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)

Table 51. Hunan Warrant Pharmaceutical SWOT Analysis

Table 52. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product and Services

Table 53. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 54. Global Remdesivir (COVID-19) Sales by Manufacturer (2018-2019) (K Units)

Table 55. Global Remdesivir (COVID-19) Revenue by Manufacturer (2018-2019) (USD Million)

Table 56. Key Players Remdesivir (COVID-19) Sales in China (2018-2019) (K Units)

Table 57. Key Players Remdesivir (COVID-19) Sales Market Share in China (2018-2019)

Table 58. Key Players Revenue of Remdesivir (COVID-19) in China (2018-2019) (USD Million)

Table 59. Global Remdesivir (COVID-19) Sales by Regions (2015-2020) (K Units)

Table 60. Global Remdesivir (COVID-19) Sales Market Share by Regions (2015-2020)

Table 61. Global Remdesivir (COVID-19) Revenue by Regions (2015-2020) (USD Million)

Table 62. Global Remdesivir (COVID-19) Sales and Forecast by Regions (2020-2025) (K Units)

Table 63. Global Remdesivir (COVID-19) Sales Market Share by Regions (2020-2025)

Table 64. Global Remdesivir (COVID-19) Revenue and Forecast by Regions (2020-2025) (USD Million)

Table 65. Global Remdesivir (COVID-19) Revenue Market Share by Regions (2020-2025) (USD Million)

Table 66. North America Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)

Table 67. North America Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)

Table 68. North America Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)

Table 69. North America Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)

Table 70. North America Remdesivir (COVID-19) Sales by Country (2020-2025) (K Units)

Table 71. North America Remdesivir (COVID-19) Sales Market Share by Country (2020-2025)

Table 72. North America Remdesivir (COVID-19) Revenue by Country (2020-2025) (USD Million)

Table 73. North America Remdesivir (COVID-19) Revenue Market Share by Country (2020-2025)

Table 74. Europe Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)

Table 75. Europe Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)

Table 76. Europe Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)

Table 77. Europe Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)

Table 78. Europe Remdesivir (COVID-19) Sales by Country (2020-2025) (K Units)

Table 79. Europe Remdesivir (COVID-19) Sales Market Share by Country (2020-2025)

Table 80. Europe Remdesivir (COVID-19) Revenue by Country (2020-2025) (USD Million)

Table 81. Europe Remdesivir (COVID-19) Revenue Market Share by Country (2020-2025)

Table 82. Asia-Pacific Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)

Table 83. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)

Table 84. Asia-Pacific Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)

Table 85. Asia-Pacific Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)

Table 86. Asia-Pacific Remdesivir (COVID-19) Sales by Country (2020-2025) (K Units)

Table 87. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Country (2020-2025)

Table 88. Asia-Pacific Remdesivir (COVID-19) Revenue by Country (2020-2025) (USD Million)

Table 89. Asia-Pacific Remdesivir (COVID-19) Revenue Market Share by Country (2020-2025)

Table 90. South America Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)

Table 91. South America Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)

Table 92. South America Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)

Table 93. South America Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)

Table 94. South America Remdesivir (COVID-19) Sales by Country (2020-2025) (K Units)

Table 95. South America Remdesivir (COVID-19) Sales Market Share by Country (2020-2025)

Table 96. South America Remdesivir (COVID-19) Revenue by Country (2020-2025) (USD Million)

Table 97. South America Remdesivir (COVID-19) Revenue Market Share by Country (2020-2025)

Table 98. Middle East & Africa Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)

Table 99. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)

Table 100. Middle East & Africa Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)

Table 101. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)

Table 102. Middle East & Africa Remdesivir (COVID-19) Sales by Country (2020-2025) (K Units)

Table 103. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Country (2020-2025)

Table 104. Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2020-2025) (USD Million)

Table 105. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Country (2020-2025)

Table 106. China Remdesivir (COVID-19) Sales by Type (2015-2020) (K Units)

Table 107. China Remdesivir (COVID-19) Sales Market Share by Type (2015-2020)

Table 108. China Remdesivir (COVID-19) Revenue by Type (2015-2020) (USD Million)

Table 109. China Remdesivir (COVID-19) Revenue Market Share by Type (2015-2020)

Table 110. China Remdesivir (COVID-19) Sales by Type (2020-2025) (K Units)

Table 111. China Remdesivir (COVID-19) Sales Market Share by Type (2020-2025)

Table 112. China Remdesivir (COVID-19) Revenue by Type (2020-2025) (USD Million)

Table 113. China Remdesivir (COVID-19) Revenue Market Share by Type (2020-2025)

Table 114. Global Remdesivir (COVID-19) Sales by Application (2015-2020) (K Units)

Table 115. Global Remdesivir (COVID-19) Sales Market Share by Application (2015-2020)

Table 116. Global Remdesivir (COVID-19) Revenue by Application (2015-2020) (USD Million)

Table 117. Global Remdesivir (COVID-19) Revenue Market Share by Application (2015-2020)

Table 118. Global Remdesivir (COVID-19) Price by Application (2015-2020) (US$/Unit)

Table 119. Global Remdesivir (COVID-19) Sales by Application (2020-2025) (K Units)

Table 120. Global Remdesivir (COVID-19) Sales Market Share by Application (2020-2025)

Table 121. Global Remdesivir (COVID-19) Revenue by Application (2020-2025) (USD Million)

Table 122. Global Remdesivir (COVID-19) Revenue Market Share by Application (2020-2025)

Table 123. Global Remdesivir (COVID-19) Price by Application (2020-2025) (US$/Unit)

Table 124. China Remdesivir (COVID-19) Sales by Application (2015-2020) (K Units)

Table 125. China Remdesivir (COVID-19) Sales Market Share by Application (2015-2020)

Table 126. China Remdesivir (COVID-19) Revenue by Application (2015-2020) (USD Million)

Table 127. China Remdesivir (COVID-19) Revenue Market Share by Application (2015-2020)

Table 128. China Remdesivir (COVID-19) Sales by Application (2020-2025) (K Units)

Table 129. China Remdesivir (COVID-19) Sales Market Share by Application (2020-2025)

Table 130. China Remdesivir (COVID-19) Revenue by Application (2020-2025) (USD Million)

Table 131. China Remdesivir (COVID-19) Revenue Market Share by Application (2020-2025)

Table 132. Direct Channel Pros & Cons

Table 133. Indirect Channel Pros & Cons

Table 134. Distributors/Traders/ Dealers List

Table 135. Customers of Remdesivir (COVID-19)

Table 136. Market Opportunities in Next Few Years

Table 137. Market Risks Analysis

Table 138. Market Drivers

List of Figures

Figure 1. Remdesivir (COVID-19) Picture

Figure 2. Global Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. 5mg Picture

Figure 4. 10mg Picture

Figure 5. 50mg Picture

Figure 6. 100mg Picture

Figure 7. Remdesivir (COVID-19) Sales Market Share by Application in 2019

Figure 8. Hospital Picture

Figure 9. Clinics Picture

Figure 10. Drug Store Picture

Figure 11. Others Picture

Figure 12. Global Remdesivir (COVID-19) Market Status and Outlook (2015-2025) (USD Million)

Figure 13. Global Remdesivir (COVID-19) Sales Growth Rate (2015-2025) (K Units)

Figure 14. Global Remdesivir (COVID-19) Sales Market Share by Manufacturer in 2019

Figure 15. Global Remdesivir (COVID-19) Revenue Market Share by Manufacturer in 2019

Figure 16. Key Players Remdesivir (COVID-19) Revenue Market Share in China in 2019

Figure 17. Global Top 5 Remdesivir (COVID-19) Manufacturer Market Share in 2019

Figure 18. Top 3 Remdesivir (COVID-19) Players Market Share in China in 2019

Figure 19. Global Remdesivir (COVID-19) Revenue Market Share by Regions in 2019

Figure 20. North America Remdesivir (COVID-19) Sales YoY Growth (2015-2025) (K Units)

Figure 21. North America Remdesivir (COVID-19) Revenue YoY Growth (2015-2025) (USD Million)

Figure 22. Europe Remdesivir (COVID-19) Sales YoY Growth (2015-2020) (K Units)

Figure 23. Europe Remdesivir (COVID-19) Revenue YoY Growth (2015-2020) (USD Million)

Figure 24. Asia-Pacific Remdesivir (COVID-19) Sales YoY Growth (2015-2020) (K Units)

Figure 25. Asia-Pacific Remdesivir (COVID-19) Revenue YoY Growth (2015-2020) (USD Million)

Figure 26. South America Remdesivir (COVID-19) Sales YoY Growth (2015-2020) (K Units)

Figure 27. South America Remdesivir (COVID-19) Revenue YoY Growth (2015-2020) (USD Million)

Figure 28. Middle East & Africa Remdesivir (COVID-19) Sales YoY Growth (2015-2020) (K Units)

Figure 29. Middle East & Africa Remdesivir (COVID-19) Revenue YoY Growth (2015-2020) (USD Million)

Figure 30. North America Remdesivir (COVID-19) Sales Market Share by Country in 2019

Figure 31. North America Remdesivir (COVID-19) Revenue Market Share by Country in 2019

Figure 32. United States Remdesivir (COVID-19) Market Size and Growth Rate (2015-2025) (USD Million)

Figure 33. Canada Remdesivir (COVID-19) Market Size and Growth Rate (2015-2025) (USD Million)

Figure 34. Mexico Remdesivir (COVID-19) Market Size and Growth Rate (2015-2020) (USD Million)

Figure 35. Europe Remdesivir (COVID-19) Revenue Market Share by Country in 2019

Figure 36. Germany Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 37. United Kingdom Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 38. France Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 39. Russia Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 40. Italy Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 41. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Region 2018

Figure 42. Asia-Pacific Remdesivir (COVID-19) Revenue Market Share by Region 2018

Figure 43. China Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 44. Japan Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 45. Korea Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 46. India Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 47. Southeast Asia Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 48. Australia Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 49. South America Remdesivir (COVID-19) Sales Market Share by Country in 2019

Figure 50. South America Remdesivir (COVID-19) Revenue Market Share by Country in 2019

Figure 51. Brazil Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 52. Argentina Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 53. Saudi Arabia Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 54. Turkey Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 55. Egypt Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 56. South Africa Remdesivir (COVID-19) Market Size Growth Rate (2015-2025) (USD Million)

Figure 57. Global Revenue Market Share of Remdesivir (COVID-19) by Type in 2019

Figure 58. Global Revenue Market Share of Remdesivir (COVID-19) by Application in 2019

Figure 59. Sales Channel: Direct Channel vs Indirect Channel